148 related articles for article (PubMed ID: 10908080)
1. Sudden death and the electrophysiological effects of angiotensin-converting enzyme inhibitors.
Maisel WH; Stevenson WG
J Card Fail; 2000 Jun; 6(2):80-2. PubMed ID: 10908080
[No Abstract] [Full Text] [Related]
2. [Symposium "Emerging Approaches to Cardiovascular Diseases: Detailed results and implications of the HOPE Study". Atlanta, 10. November 1999].
Bischoff A
Internist (Berl); 2000 Jan; 41(1):A24-7. PubMed ID: 10712083
[No Abstract] [Full Text] [Related]
3. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.
Singh SN; Karasik P; Hafley GE; Pieper KS; Lee KL; Wyse DG; Buxton AE;
Am J Cardiol; 2001 Mar; 87(6):716-20. PubMed ID: 11249889
[TBL] [Abstract][Full Text] [Related]
4. The use of angiotensin converting enzyme inhibitors in asymptomatic patients with left ventricular dysfunction after myocardial infarction.
Bazunga M
Conn Med; 1995 Nov; 59(11):663-6. PubMed ID: 8565511
[No Abstract] [Full Text] [Related]
5. Sudden cardiac death after heart failure; symptomatic versus disease treatment? An editorial comment.
Buckberg GD;
Heart Fail Rev; 2004 Oct; 9(4):347-51. PubMed ID: 15886980
[No Abstract] [Full Text] [Related]
6. Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarction.
Tuininga YS; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC; Crijns HJ
J Card Fail; 2000 Jun; 6(2):77-9. PubMed ID: 10908079
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
Kochs M; Eggeling T; Hombach V
Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and angiotensin-converting enzyme inhibitors are safe when taken together after acute myocardial infarction in patients with left ventricular dysfunction.
Basile JN
J Clin Hypertens (Greenwich); 2001; 3(6):376-7. PubMed ID: 11723360
[No Abstract] [Full Text] [Related]
9. How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?
Cleland JG; Puri S
Br Heart J; 1994 Sep; 72(3 Suppl):S81-6. PubMed ID: 7946810
[No Abstract] [Full Text] [Related]
10. [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Kanopskiĭ SG; Staritskiĭ AG; Bozhko AA
Kardiologiia; 2004; 44(10):13-8. PubMed ID: 15477784
[TBL] [Abstract][Full Text] [Related]
11. Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial.
Piccini JP; Zhang M; Pieper K; Solomon SD; Al-Khatib SM; Van de Werf F; Pfeffer MA; McMurray JJ; Califf RM; Velazquez EJ
Eur Heart J; 2010 Jan; 31(2):211-21. PubMed ID: 19854729
[TBL] [Abstract][Full Text] [Related]
12. [Randomized multicenter study PRESTIGE: assessment of efficacy of perindopril as compared with captopril in patients with acute myocardial infarction with left ventricular dysfunction].
Belenkov IuN; Arutiunov GP; Glezer MG; Zadionchenko VM; Matrynov AI; Moiseev VS; Pozdniakov IuM; Storozhakov GI; Striuk RI; Tereshchenko SN
Kardiologiia; 2005; 45(5):22-9. PubMed ID: 16007044
[No Abstract] [Full Text] [Related]
13. Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study.
Torp-Pedersen C; Køber L; Carlsen J
Am Heart J; 1996 Jul; 132(1 Pt 2 Su):235-43. PubMed ID: 8677862
[TBL] [Abstract][Full Text] [Related]
14. [Trandolapril in patients with left ventricular insufficiency after myocardial infarction].
Aliot E
Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():23-31. PubMed ID: 8949315
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin-converting enzyme inhibitor therapy on QT dispersion post acute myocardial infarction.
Kassotis J; Mongwa M; Reddy CV
Pacing Clin Electrophysiol; 2003 Apr; 26(4 Pt 1):843-8. PubMed ID: 12715844
[TBL] [Abstract][Full Text] [Related]
16. [Neurohumoral systems escape control. Heart failure symptoms even once--long-term high risk prognosis].
MMW Fortschr Med; 2005 Jul; 147(27-28):45. PubMed ID: 16041943
[No Abstract] [Full Text] [Related]
17. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
18. [Angiotensin-converting enzyme inhibitors. Principles and rules of their use].
Juillière Y
Rev Prat; 2001 Sep; 51(14):1601-7. PubMed ID: 11757278
[No Abstract] [Full Text] [Related]
19. From left ventricular dysfunction to heart failure.
Cleland JG
Arch Mal Coeur Vaiss; 1996 Nov; 89(11):1397-402. PubMed ID: 9092398
[TBL] [Abstract][Full Text] [Related]
20. Indications for immediate angiotensin-converting enzyme inhibition in patients with acute myocardial infarction.
LeJemtel TH; Hochman JS; Sonnenblick EH
J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):47S-51S. PubMed ID: 7775715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
